The subprogram of non-oriented basic research projects of the Ministry of Science and Innovation (MICINN) will fund 20 projects IDIBELL with about three million Euros, according to the preliminary resolution.
Spanish Ministry of Science and Innovation funds twenty IDIBELL research projects Read More »
The finding may enable progress towards personalized treatments in these kinds of tumors Inhibition of epidermal growth factor receptor (EGFR) impairs the growth of liver tumor cells and makes them sensitive to the suppressive action of the cytokine TGF-beta, by activating mechanisms of programmed death (apoptosis). This is the result of research conducted by researchers from the Biological clues of the invasive and metastatic phenotype group at IDIBELL, led by Isabel Fabregat. Dual role of TGF – beta Article reference
The Research Results Transfer Office (OTRI) and the Research Support Office (ORS) IDIBELL launches new space after the renovations. The renewed OTRI nearly doubles its space from about 70m2 to 135m2 and has more actual daylight. It is structured in three different areas: one for competitive projects, another for non competitive ones and a new meeting room.
OTRI wins meters and facilities for researchers Read More »
The research has been published in Clinical Oral Implants Research journal Sutures made with Teflon thread are more comfortable for patients than the sutures of silk thread, according to a scientific article that reviews the use of these two non-absorbable suture materials in oral implantology. The article has been published in Clinical Oral Implants Research journal, led by Cosme Gay-Escoda, researcher at the Pathology and Dental Therapeutics and Maxillofacial group at IDIBELL and the University of Barcelona. Article reference: Source
A study compares silk and Teflon sutures in dental implant surgery Read More »
The Spanish Clinical Research Network (CAIBER) incorporates five clinical trials led by researchers at the IDIBELL to Plan Clinical Research after obtaining a favorable resolution and excellent grades in the 2010 Intramural call. IDIBELL projects
Five clinical trials led by IDIBELL will form part of the CAIBER Clinical Research Plan Read More »
IDIBELL has signed a collaboration agreement with the Foundation Step By Step, dedicated to the recovery of spinal injuries, to promote and support new research in the field of spinal cord injury. Step by Step
The Spanish Society of Genetics has rewarded the IDIBELL researcher in genetic applications category The Spanish Society of Genetics (SEG) and the Foundation Pryconsa have distinguished the contributions of the IDIBELL researcher, Manel Esteller, in the research on genetic application in the III Edition of the National Genetics Awards to be delivered under the XXXVIII SEG Congress, to be held from 21 to 23 September in Murcia. Manel Esteller Profile
Manel Esteller, National Genetics Award 2011 Read More »
The group of Metabolism and cellular signals at Biomedical Research Institute Alberto Sols led by Juan Manuel Zapata focuses its research on studying the regulation of TNF receptor, TRAF family of proteins and how changes in abnormal expression of these proteins may be involved in the development of leukemia or lymphoma. Zapata explained his progress in the last session of IDIBELL series of seminars held on July 8.
The year 2011 marks the International Year of Women Scientists just one hundred years after it was first awarded a Nobel Prize to a scientist, Marie Curie. In this context, on July 4 was held a meeting on the invisibility of female talent organized by ‘fem.talent’ project and Biopol’H. More information about the meeting: http://www.biopol.cat/cat/noticias/
The researcher and Professor of Nuclear Medicine at Rabdoud University, Nijmegen (Netherlands), Wim Oyen, explained its progress in the implementation of FDG/PET imaging technique to improve the diagnosis of various diseases and facilitate the process of therapeutic decision. It was on July 1st as part of the seminars IDIBELL.
Wim Oyen:”Getting the best diagnosis in the shortest time” Read More »
